Big Earnings Afternoon: Microsoft, Alphabet, Starbucks & More
https://www.zacks.com/stock/news/2218328/big-earnings-afternoon-microsoft-alphabet-starbucks-more?cid=CS-ZC-FT-ahead_of_wall_street-2218328
Jan 30, 2024 - Microsoft, Google-parent Alphabet, Mondelez and Skyworks all topped earnings expectations.
0
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2218712/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2218712
Jan 31, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214
Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.
0
Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
https://www.zacks.com/stock/news/2221276/novo-nordisk-nvo-to-acquire-3-catalent-sites-for-11b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221276
Feb 05, 2024 - Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
0
Why Novo Nordisk (NVO) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2224747/why-novo-nordisk-nvo-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2224747
Feb 12, 2024 - The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
0
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
https://www.zacks.com/stock/news/2235993/new-to-investing-this-1-medical-stock-could-be-the-perfect-starting-point?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2235993
Mar 05, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
0
Pharma Stock Roundup: NVO's New Obesity Pill Data, RHHBY, AZN's Pipeline Updates
https://www.zacks.com/stock/news/2238322/pharma-stock-roundup-nvo-s-new-obesity-pill-data-rhhby-azn-s-pipeline-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2238322
Mar 08, 2024 - Novo Nordisk???s (NVO) early-stage data on a new weight loss pill, amycretin, shows it can outperform Wegovy. FDA approves J&J???s (JNJ) Rybrevant for first-line use.
0
Top Research Reports for Novo Nordisk, Tesla & Airbnb
https://www.zacks.com/commentary/2239296/top-research-reports-for-novo-nordisk-tesla-airbnb?cid=CS-ZC-FT-research_daily-2239296
Mar 12, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Tesla, Inc. (TSLA) and Airbnb, Inc. (ABNB).
0
Why Novo Nordisk (NVO) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2241407/why-novo-nordisk-nvo-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2241407
Mar 15, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Wall Street Awaits Consumer Confidence Data
https://www.zacks.com/stock/news/2246106/wall-street-awaits-consumer-confidence-data?cid=CS-ZC-FT-economic_highlights-2246106
Mar 26, 2024 - Wall Street Awaits Consumer Confidence Data
0